Chief Medical Officer, Bio-Techne
BIOGRAPHY
NOV 20, 2020 10:00 AM PST
Companion Diagnostic and Biomarker Assay Development for Interrogation of Liquid and Solid Tumor Biopsies - From RNAscope to Exosomes
Speakers
-
Christopher Bunker, Ph.D., MBA
Sr. Director, Business Development, Advanced Cell Diagnostics, a Bio-Techne BrandBIOGRAPHY -
Michael D Valentino, Ph.D.
Scientific Director of Companion Diagnostics within the Business Development team at Exosome Diagnostics, a Bio-Techne BrandBIOGRAPHY
Event Date & Time
Date: November 20, 2020
Time: 10:00am (PST), 1:00pm (EST)
Abstract
This webinar will provide an overview of the Bio-Techne technologies being used by Biopharma for the development of biomarkers and companion diagnostic assays to support their therapeutic programs, including tissue-based and liquid biopsy approaches. In particular, the RNAscope technology and its utility as a companion diagnostic platform for tissue-based testing of biomarker expression and patient selection will be reviewed. In addition, the use of exosomes in the development of biomarkers for oncology, neurologic diseases, and other conditions will be highlighted.
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...